Inogen traded at $5.22 this Friday September 25th, decreasing $0.01 or 0.19 percent since the previous trading session. Looking back, over the last four weeks, Inogen lost 6.12 percent. Over the last 12 months, its price fell by 36.50 percent. Looking ahead, we forecast Inogen to be priced at 5.03 by the end of this quarter and at 4.71 in one year, according to Trading Economics global macro models projections and analysts expectations.
Inogen, Inc. is a medical technology company that develops, manufactures and markets portable oxygen concentrators (POCs). Its POCs is used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a single battery. Its product offering includes Inogen One G5, Inogen One G4, and Inogen One G3, for long-term oxygen therapy. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology from which the patient receives a bolus of oxygen upon inhalation. The Company has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.